• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:美泊利珠单抗治疗特发性慢性嗜酸性粒细胞肺炎。

Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia.

机构信息

University of Tunis El Manar, Tunis, Tunisia.

Pneumology, Military Hospital of Tunis, Tunis, 1008, Tunisia.

出版信息

F1000Res. 2023 Sep 5;12:337. doi: 10.12688/f1000research.130939.2. eCollection 2023.

DOI:10.12688/f1000research.130939.2
PMID:37691733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10483178/
Abstract

Idiopathic chronic eosinophilic pneumonia (ICEP) is a rare interstitial lung disease of unknown cause. It usually responds well to systemic corticosteroid therapy, but relapses are frequent. We describe two cases of 21- and 27-year-old patients, presenting with dyspnea. The diagnosis of steroid-relapsing and steroid-dependent ICEP was made respectively. Mepolizumab was prescribed to both patients. This treatment resulted in successful long-term disease management with much fewer side effects than a traditional corticosteroid therapy.

摘要

特发性慢性嗜酸性粒细胞性肺炎(ICEP)是一种病因不明的罕见间质性肺疾病。它通常对全身皮质类固醇治疗反应良好,但复发频繁。我们描述了两例分别为 21 岁和 27 岁的患者,表现为呼吸困难。诊断为激素复发和激素依赖的 ICEP。 为两名患者都开了美泊利珠单抗。与传统的皮质类固醇治疗相比,这种治疗在减少副作用的情况下成功地进行了长期疾病管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a0/10513375/712449fb11b0/f1000research-12-155328-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a0/10513375/cd8afaed217e/f1000research-12-155328-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a0/10513375/66110791f27c/f1000research-12-155328-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a0/10513375/712449fb11b0/f1000research-12-155328-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a0/10513375/cd8afaed217e/f1000research-12-155328-g0000.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a0/10513375/66110791f27c/f1000research-12-155328-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84a0/10513375/712449fb11b0/f1000research-12-155328-g0002.jpg

相似文献

1
Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia.病例报告:美泊利珠单抗治疗特发性慢性嗜酸性粒细胞肺炎。
F1000Res. 2023 Sep 5;12:337. doi: 10.12688/f1000research.130939.2. eCollection 2023.
2
Anti-IL5 therapies for asthma.用于哮喘的抗白细胞介素-5疗法。
Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD010834. doi: 10.1002/14651858.CD010834.pub3.
3
Healing chronic idiopathic eosinophilic pneumonia using mepolizumab alone without corticosteroids.单独使用美泊利珠单抗而非皮质类固醇治疗慢性特发性嗜酸性粒细胞性肺炎。
Wien Klin Wochenschr. 2024 Aug 8. doi: 10.1007/s00508-024-02406-5.
4
Anti-IL-5 therapies for asthma.哮喘的抗 IL-5 治疗。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD010834. doi: 10.1002/14651858.CD010834.pub4.
5
Successful management of chronic eosinophilic pneumonia triggered by immune checkpoint inhibitor: a case report and literature review.免疫检查点抑制剂引发的慢性嗜酸性粒细胞性肺炎的成功管理:一例报告及文献综述
Front Immunol. 2025 Jul 22;16:1615531. doi: 10.3389/fimmu.2025.1615531. eCollection 2025.
6
Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia.特发性慢性嗜酸性粒细胞性肺炎中美泊利单抗的真实生活研究。
Lung. 2020 Apr;198(2):355-360. doi: 10.1007/s00408-020-00336-3. Epub 2020 Feb 12.
7
Role of Monoclonal Antibodies in the Management of Eosinophilic Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials.单克隆抗体在嗜酸性慢性阻塞性肺疾病管理中的作用:一项随机对照试验的荟萃分析
Ann Am Thorac Soc. 2025 May;22(5):768-775. doi: 10.1513/AnnalsATS.202406-597OC.
8
Mepolizumab versus placebo for asthma.美泊利珠单抗对比安慰剂治疗哮喘
Cochrane Database Syst Rev. 2015 Jul 27(7):CD010834. doi: 10.1002/14651858.CD010834.pub2.
9
Drug evaluation: mepolizumab in chronic obstructive pulmonary disease.药物评估:美泊利单抗治疗慢性阻塞性肺疾病
Immunotherapy. 2025 Apr;17(6):399-408. doi: 10.1080/1750743X.2025.2504326. Epub 2025 May 14.
10
Two unique cases of eosinophilic granulomatosis with polyangiitis in childhood treated with anti-interleukin-5 therapy: infantile-onset and submandibular salivary gland involvement.两例儿童嗜酸性肉芽肿性多血管炎采用抗白细胞介素-5治疗的独特病例:婴儿期起病并累及下颌下唾液腺
Pediatr Rheumatol Online J. 2025 Jun 2;23(1):60. doi: 10.1186/s12969-025-01115-1.

引用本文的文献

1
The clinical question of mepolizumab in the long-term treatment of idiopathic chronic eosinophilic pneumonia; how long should we use mepolizumab?美泊利珠单抗用于特发性慢性嗜酸性粒细胞性肺炎长期治疗的临床问题;我们应该使用美泊利珠单抗多长时间?
Respir Med Case Rep. 2024 Nov 13;52:102142. doi: 10.1016/j.rmcr.2024.102142. eCollection 2024.
2
Successful Treatment of Relapsing Chronic Eosinophilic Pneumonia With Mepolizumab: A Case Report.美泊利单抗成功治疗复发性慢性嗜酸性粒细胞性肺炎:一例报告
Cureus. 2024 Jul 22;16(7):e65097. doi: 10.7759/cureus.65097. eCollection 2024 Jul.

本文引用的文献

1
Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia.靶向白细胞介素-5/白细胞介素-5受体用于治疗特发性慢性嗜酸性粒细胞性肺炎。
J Allergy Clin Immunol Pract. 2023 Apr;11(4):1317-1319.e1. doi: 10.1016/j.jaip.2022.12.022. Epub 2022 Dec 26.
2
Relapsing chronic eosinophilic pneumonia treated successfully with benralizumab.使用贝那利珠单抗成功治疗复发性慢性嗜酸性粒细胞性肺炎。
Ann Allergy Asthma Immunol. 2021 Jun;126(6):726-727. doi: 10.1016/j.anai.2021.02.016. Epub 2021 Feb 24.
3
Efficacy of Mepolizumab Extended Interval Dosing for 2 Asthmatic Patients With Chronic Eosinophilic Pneumonia.
美泊利单抗延长给药间隔对2例慢性嗜酸性粒细胞性肺炎哮喘患者的疗效
J Investig Allergol Clin Immunol. 2021 Oct 25;31(5):459-460. doi: 10.18176/jiaci.0671. Epub 2021 Jan 27.
4
Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance.美泊利珠单抗:一种用于糖皮质激素不耐受的特发性慢性嗜酸性粒细胞性肺炎的替代疗法。
Drugs Context. 2020 Aug 18;9. doi: 10.7573/dic.2020-5-3. eCollection 2020.
5
Lung-limited or lung-dominant variant of eosinophilic granulomatosis with polyangiitis.嗜酸性肉芽肿性多血管炎的肺部局限性或肺部为主型变异型。
J Allergy Clin Immunol Pract. 2020 Jun;8(6):2092-2095. doi: 10.1016/j.jaip.2020.01.058. Epub 2020 Mar 2.
6
Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia.特发性慢性嗜酸性粒细胞性肺炎中美泊利单抗的真实生活研究。
Lung. 2020 Apr;198(2):355-360. doi: 10.1007/s00408-020-00336-3. Epub 2020 Feb 12.
7
Anti-interleukin (IL)-5 as a steroid-sparing agent in chronic eosinophilic pneumonia.抗白细胞介素(IL)-5作为慢性嗜酸性粒细胞性肺炎中的一种类固醇节省剂。
J Asthma. 2020 Jan;57(1):82-86. doi: 10.1080/02770903.2018.1543434. Epub 2018 Nov 16.
8
Favorable response to asthma-dosed subcutaneous mepolizumab in eosinophilic pneumonia.嗜酸性粒细胞性肺炎患者对哮喘剂量皮下注射美泊利单抗反应良好。
J Asthma. 2019 Nov;56(11):1193-1197. doi: 10.1080/02770903.2018.1534966. Epub 2018 Nov 5.
9
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.评估美泊利珠单抗治疗重度嗜酸性粒细胞性哮喘的长期安全性和临床应答的持久性。
J Allergy Clin Immunol. 2019 May;143(5):1742-1751.e7. doi: 10.1016/j.jaci.2018.09.033. Epub 2018 Oct 23.
10
A case of chronic eosinophilic pneumonia successfully treated with mepolizumab.1例用美泊利单抗成功治疗的慢性嗜酸性粒细胞性肺炎病例。
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1746-1748.e1. doi: 10.1016/j.jaip.2018.06.017. Epub 2018 Jul 7.